This bill terminates on December 1, 2021, certain protections from liability that apply to manufacturers of COVID-19 vaccines. Currently, the liability protections generally expire on October 1, 2024, unless the underlying declaration of emergency is rescinded earlier.
To amend title III of the Public Health Service Act to terminate the 
   effective time period for immunity for manufacturers of COVID-19 
                   vaccines, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. LIABILITY OF COVID-19 VACCINE MANUFACTURERS.

    Notwithstanding any other provision of law, in applying section XII 
of the ``Declaration Under the Public Readiness and Emergency 
Preparedness Act for Medical Countermeasures Against COVID-19'' issued 
pursuant to section 319F-3(b)(2)(B) of the Public Health Service Act 
(42 U.S.C. 247d-6d(b)(2)(B)), with respect to manufacturers of COVID-19 
vaccines, the reference to October 1, 2024, shall be deemed a reference 
to December 1, 2021.
                                 <all>
To amend title III of the Public Health Service Act to terminate the effective time period for immunity for manufacturers of COVID-19 vaccines, and for other purposes.
To amend title III of the Public Health Service Act to terminate the effective time period for immunity for manufacturers of COVID-19 vaccines, and for other purposes.
Official Titles - House of Representatives
Official Title as Introduced
To amend title III of the Public Health Service Act to terminate the effective time period for immunity for manufacturers of COVID-19 vaccines, and for other purposes.
Rep. Gooden, Lance